Displaying 126 - 150 of 1556
Source:
Test
Methodology:
FISH
BCL6/MYC t(3;8)
Alternative Name
BCL6/MYC Translocation
Methodology
FISH
Test Description
Probes: BCL6/MYC t(3;8)
Disease(s): B-cell lymphoma, double-hit lymphoma,…
Source:
Test
Methodology:
Molecular
BCR-ABL1 Non-Standard p230
Alternative Name
BCR-ABL1 p230 Translocation, BCR/ABL1 Non-Standard
Methodology
Molecular
Test Description
Real-time RT-PCR for detection of…
Source:
Test
Methodology:
Molecular
BCR-ABL1 Standard p210, p190
Alternative Name
Philadelphia chromosome, BCR-ABL1 Major, BCR-ABL1 Minor, BCR/ABL1 Standard
Methodology
Molecular
Test Description
Real-…
Source:
Test
Methodology:
FISH
BCR/ABL1/ASS1 t(9;22)
Alternative Name
Philadelphia chromosome, Philadelphia translocation
Methodology
FISH
Test Description
Probes: ABL1 (9q34); ASS1 (9q34; BCR (…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
BerEP4
Methodology
Immunohistochemistry (IHC)
Test Description
Ber-EP4 recognizes two glycoproteins of 34 and 49 kDa present on the surface and the cytoplasm of all epithelial cells except the…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Beta Catenin
Methodology
Immunohistochemistry (IHC)
Test Description
Beta-catenin is an important regulator of cell–cell adhesion and embryogenesis. Mutations of beta-catenin could lead to some human…
Source:
Test
Methodology:
FISH
BIRC3(API2)/MALT1 t(11;18)
Alternative Name
MALT lymphoma
Methodology
FISH
Test Description
Probes: BIRC3(API2)/MALT1 t(11;18)
Disease(s): MALT lymphoma, NHL…
Source:
Test
Methodology:
FISH
Bladder Cancer
Methodology
FISH
Test Description
Probes: +3 (Cen 3) | +7 (Cen 7) | p16 (9p21) | +17 (Cen 17)
Disease(s): Bladder cancer
Clinical Significance
This…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
BOB1
Methodology
Immunohistochemistry (IHC)
Test Description
BOB1 is present in all B-cells expressing Ig. The combination of BOB1 and OCT2 staining is helpful in distinguishing between classical…
Source:
Test
Methodology:
Molecular
Bone Marrow Failure NGS Panel
Methodology
Molecular
Test Description
Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics Informed…
Source:
Test
Methodology:
Molecular
BRAF Mutation Analysis by PCR
Alternative Name
BRAF V600
Methodology
Molecular
Test Description
BRAF Mutation Analysis Assay is based on PCR amplification and…
Source:
Test
Methodology:
FISH
BRAF Rearrangement
Alternative Name
BRAF translocation
Methodology
FISH
Test Description
Probes: BRAF (7q34)
Disease(s): Brain cancer, thyroid cancer, melanoma…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
BRAF V600E
Methodology
Immunohistochemistry (IHC)
Test Description
A monoclonal antibody (IHC600) against mutant BRAF (V600E) permits fast assessment of the mutant protein expression throughout a…
Source:
Test
Methodology:
Molecular
Brain NGS Fusion Panel
Alternative Name
Brain Tumor Fusion Panel
Methodology
Molecular
Test Description
The Brain Tumor NGS Fusion Panel is an RNA-based next-…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
BRCA1
Methodology
Immunohistochemistry (IHC)
Test Description
BRCA1 (breast and ovarian cancer susceptibility protein 1) is a nuclear phosphoprotein that plays a role in maintaining genomic stability…
Source:
Test
Methodology:
Molecular
BRCA1 and BRCA2 Focus Panel (Germline)
Methodology
Molecular
Test Description
Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics…
Source:
Test
Methodology:
Molecular
BRCA1 Single Gene (Germline)
Methodology
Molecular
Test Description
Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics Informed…
Source:
Test
Methodology:
Molecular
BRCA1/2 Mutation Analysis for Tumors
Methodology
Molecular
Test Description
BRCA1 and BRCA2 mutation analysis is performed by next-generation sequencing of all coding exons of the BRCA1 and BRCA2…
Source:
Test
Methodology:
Molecular
BRCA2 Single Gene (Germline)
Methodology
Molecular
Test Description
Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on the Fulgent Genetics …
Source:
Announcement
Breast Cancer Awareness
NeoGenomics leverages its leadership in precision diagnostics to deliver a complete suite of tests that meet clinical demands throughout the breast cancer journey.For any…
Source:
Test
Methodology:
Molecular
Breast Cancer Index® (BCI)
Methodology
Molecular
Test Description
Breast Cancer Index (BCI) is an RT-PCR assay performed on FFPE breast tumor tissue that integrates two gene expression-based…
Source:
Test
Methodology:
Molecular
Breast NGS Fusion Panel
Alternative Name
Breast Fusion Panel
Methodology
Molecular
Test Description
The Breast NGS Fusion Panel is an RNA-based next-generation…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Breast Triple Stain (CK5 + p63 + CK 8/18)
Methodology
Immunohistochemistry (IHC)
Test Description
The combination of CK5 + P63 + CK8/18 (Breast Triple Stain) can be useful in distinguishing ductal…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
BRG1 (SMARCA4)
Methodology
Immunohistochemistry (IHC)
Test Description
BRG1 (SMARCA4) is involved in chromatin remodeling, which regulates the binding of transcription factors to DNA.…
Source:
Test
Methodology:
Molecular
BTK Inhibitor Acquired Resistance Panel
Alternative Name
BTK, BTK acquired resistance
Methodology
Molecular
Test Description
Concurrent bi-directional sequencing of…